Structural plasticity associated with exposure to drugs of abuse.
about
Altered frontal cortical volume and decision making in adolescent cannabis usersTranscriptional mechanisms of drug addictionMolecular neurobiology of addiction: what’s all the (Δ)FosB about?Methylphenidate-induced dendritic spine formation and DeltaFosB expression in nucleus accumbensTranscriptional and epigenetic mechanisms of addictionNatural rewards, neuroplasticity, and non-drug addictionsInteraction of the mu-opioid receptor with GPR177 (Wntless) inhibits Wnt secretion: potential implications for opioid dependenceBrain circuits regulating energy homeostasisCellular basis of memory for addictionBrain reward circuitry beyond the mesolimbic dopamine system: a neurobiological theoryExperience and the developing prefrontal cortexReview. Transcriptional mechanisms of addiction: role of DeltaFosBNeural substrates of cognitive inflexibility after chronic cocaine exposureEarly life exposure to a high fat diet promotes long-term changes in dietary preferences and central reward signalingFischer 344 and Lewis Rat Strains as a Model of Genetic Vulnerability to Drug AddictionNociception, Pain, Negative Moods, and Behavior SelectionAbnormal kalirin signaling in neuropsychiatric disorders.Molecular mechanisms of activity-dependent changes in dendritic morphology: role of RGK proteinsAdult hippocampal neurogenesis in the pathogenesis of addiction and dual diagnosis disordersThe use of neuroproteomics in drug abuse researchRoles of the ubiquitin proteasome system in the effects of drugs of abuseRole of nucleus accumbens glutamatergic plasticity in drug addictionAnisomycin in the medial prefrontal cortex reduces reconsolidation of cocaine-associated memories in the rat self-administration modelSynaptic Cytoskeletal Plasticity in the Prefrontal Cortex Following Psychostimulant ExposureThe influence of stress and gonadal hormones on neuronal structure and functionPhosphorylation of DARPP-32 at Threonine-34 is required for cocaine actionThe role of CB1 receptors in psychostimulant addictionHeroin self-administration: II. CNS gene expression following withdrawal and cue-induced drug-seeking behaviorMechanisms of psychostimulant-induced structural plasticityMethamphetamine preconditioning alters midbrain transcriptional responses to methamphetamine-induced injury in the rat striatumEnhanced anxiety observed in cocaine withdrawn rats is associated with altered reactivity of the dorsomedial prefrontal cortexNatural reward experience alters AMPA and NMDA receptor distribution and function in the nucleus accumbensTransforming growth factor beta receptor 1 is increased following abstinence from cocaine self-administration, but not cocaine sensitizationOpposite Effects of mGluR1a and mGluR5 Activation on Nucleus Accumbens Medium Spiny Neuron Dendritic Spine DensityGenome-Wide Association of Heroin Dependence in Han ChineseA sensitizing D-amphetamine dose regimen induces long-lasting spinophilin and VGLUT1 protein upregulation in the rat diencephalonStress-induced sensitization to cocaine: actin cytoskeleton remodeling within mesocorticolimbic nucleiEffect of cocaine on Fas-associated protein with death domain in the rat brain: individual differences in a model of differential vulnerability to drug abuseSignaling pathway adaptations and novel protein kinase A substrates related to behavioral sensitization to cocaineTranscriptional response of rat frontal cortex following acute in vivo exposure to the pyrethroid insecticides permethrin and deltamethrin
P2860
Q21558374-88C224F2-8535-44C1-81CD-C029C31F3D9EQ22241120-C84E9D28-CD72-4DB7-8A13-2B1B509C267EQ22241263-DFAE136E-E097-49DA-AF82-DCFCE020C639Q22248089-69D648E9-AD1B-4705-8B96-0D2990CB723EQ22251017-75244C0A-59BA-49D1-858F-ED2C70853BF9Q22251254-059632F9-0CF2-4630-99D1-2F7B31333AA6Q24302002-E96FBBAF-640A-4CAB-AB7D-E8FD4CF19193Q24569806-EBE390DC-2A07-4D90-AFEF-A529E26A9FC0Q24615131-5508B24B-8645-423F-AF6C-2923B4EB60F5Q24625428-4ECF9470-D202-4A8F-8B20-6A939E8C61ACQ24626794-C62E0CA4-AEC3-468F-972B-8BE808D95594Q24642005-0416FBA1-4784-405A-AE46-83C6CE6C8CE7Q24648658-EEC33ECB-0CEF-4180-B76C-C197DD75E65CQ24655015-C12FDF88-8321-4971-987F-60325AC2BCA7Q26768236-69059F5F-51AF-42DA-8D1C-05EFDCA01FD9Q26801530-C141E440-57FA-40D5-B25D-3EA2568F6C12Q26824648-F897329F-F029-4012-BE54-AC91FB928945Q26851882-9AD101F6-E6B9-4311-A3FA-86A232106F6EQ26852192-51B74833-A863-4B45-9FB6-1337E1375CE5Q27010380-76D65F98-EE69-4674-AC96-938601C3D336Q27011348-DB0156A7-5401-40F8-80F6-8A63DCDCF40CQ27013753-907109D8-BA21-4DE9-8DE5-B168D7EDCC11Q27305155-AA79C947-A004-4924-BCF8-26B672BF4667Q28084365-32DEE1B9-20BF-4F98-8370-500BAC3BAF1EQ28088471-84E0E112-000D-45FF-88BA-C188BCAAAC99Q28269125-B4062DAB-8D6E-48AB-97D8-F8079D7E4036Q28280265-2794C01B-393D-4875-A847-9A4DD773FC13Q28386419-C10E822A-1698-4C9F-AB1B-5D0C4CDB2C8CQ28389962-C81BFCA7-7E7F-46EA-82EA-F77ACAF96446Q28471860-332B4B39-4759-4A87-AEDD-B38291D36C8AQ28482300-3F46CDEF-A9F8-465C-97CD-C6FF525B1897Q28482410-D249C7E6-3D38-4266-AABB-B12DA1030C1BQ28538088-942A8F7B-E6AD-49FD-AC52-232D79999530Q28554014-09E97EC1-E3D6-47A3-9793-95BF2FD52A7CQ28554877-24CE66B9-FD21-4B3A-8146-2888882EEE02Q28567989-14D90C4B-DEAE-422B-916B-C24B3295075BQ28573964-191686CC-CED0-40F3-95C0-6B3EA8EC240FQ28574580-3DCD5EC3-992B-41DC-A5E1-F9A5C43A2C86Q28576544-5BA844C9-D514-4376-9198-9A25A6662BB5Q28578306-826C269D-9E89-4429-BD1D-648BCAC23573
P2860
Structural plasticity associated with exposure to drugs of abuse.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Structural plasticity associated with exposure to drugs of abuse.
@ast
Structural plasticity associated with exposure to drugs of abuse.
@en
type
label
Structural plasticity associated with exposure to drugs of abuse.
@ast
Structural plasticity associated with exposure to drugs of abuse.
@en
prefLabel
Structural plasticity associated with exposure to drugs of abuse.
@ast
Structural plasticity associated with exposure to drugs of abuse.
@en
P1433
P1476
Structural plasticity associated with exposure to drugs of abuse.
@en
P2093
Bryan Kolb
Terry E Robinson
P356
10.1016/J.NEUROPHARM.2004.06.025
P478
47 Suppl 1
P577
2004-01-01T00:00:00Z